Treatments for Plaque Psoriasis

>

Latest News

Patient Preferences in Topical Psoriasis Treatment
Patient Preferences in Topical Psoriasis Treatment

April 20th 2023

A new study revealed that psoriasis patient adherence is influenced by certain characteristics of topical medications.

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis
Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis
Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis

September 10th 2022

psoriasis
Study: Risk of Psoriasis Related to BMI

December 21st 2021

psoriasis
Apremilast Use During COVID-19

December 21st 2021

More News

Site Logo

Many with psoriasis go untreated

Staff reports
August 20th 2013

Up to 30 percent of patients with psoriasis do not seek medical care for their skin condition, patient surveys show.

Site Logo

Low rate of adverse events with adalimumab in long term

Staff reports
April 1st 2013

The rate of adverse events in patients using adalimumab remains low over time, with infections indicated as the most common adverse event, according to a study.

Site Logo

Derms may be first to spot cardiovascular risk in psoriasis patients

Paula Moyer
April 1st 2013

People who live with psoriasis have a higher risk of death from cardiovascular disease.

Site Logo

AAD launches psoriasis guideline app

March 4th 2013

A new smartphone application from the American Academy of Dermatology provides evidence-based clinical guidelines for treating patients with psoriasis and psoriatic arthritis.

<12345
© 2024 MJH Life Sciences

All rights reserved.